Avicanna Inc. (OTCMKTS:AVCNF) Sees Significant Decrease in Short Interest

Avicanna Inc. (OTCMKTS:AVCNF) saw a large decrease in short interest during the month of June. As of June 15th, there was short interest totaling 40,987 shares, a decrease of 80.0% from the May 31st total of 204,945 shares. Based on an average daily trading volume, of 305,425 shares, the days-to-cover ratio is presently 0.1 days.

Avicanna Price Performance

Shares of Avicanna stock opened at $0.09 on Friday. Avicanna has a 12-month low of $0.07 and a 12-month high of $0.24. The company’s fifty day simple moving average is $0.10 and its two-hundred day simple moving average is $0.13.

Avicanna Company Profile

Avicanna Inc, a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide. It commercializes approximately thirty proprietary evidence-based finished products. The company provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, such as Trunerox, an adjuvant treatment for seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome.